 |
|
|
| |
Same same but different? Risk of DAA therapy
failure in real-life HCV/HIV coinfection: The GECCO Cohort
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
Christoph Boesecke1,2, Patrick Ingiliz3, Florian Berger4, Thomas Lutz5, Knud Schewe6, Julian Schulze zur Wiesch7,
Axel Baumgarten3, Stefan Christensen8, Jürgen K Rockstroh1,2, Stefan Mauss4for the GECCO study group
1University Hospital Bonn, Bonn, Germany; 2German Centre for Infection Research (DZIF), Partner Site Cologne-Bonn, Bonn, Germany; 3Center for InfectiologyBerlin (CIB), Berlin, Germany; 4Center for HIV and Hepatogastroenterology, Düsseldorf, Germany; 5Infektiologikum, Frankfurt, Germany; 6Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany; 7University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 8CIM Infectious Diseases, Münster, Germany
|
| |
|
|
|
|
|
